International Journal of Advances in Pharmacy Medicine and Bioallied Sciences (Int J Adv Pharm Med Bioallied Sci; IJAPMBS) is an international, multidisciplinary, peer-reviewed, open access, quarterly published biomedical journal. IJAPMBS publishes newer dynamic findings in the broad fields of Pharmacy, Medicine, Biotechnology, Life Sciences, Toxicology and other Basic Medical Sciences. The aim of IJAPMBS is to prove an academic communication platform of scientific excellence and information exchange for international physicians, pharmaceutical & medical scientists, allied health personnel and public health workers.

Int J Adv Pharm Med Bioallied Sci welcomes submissions from authors worldwide for original research articles, short communications, reviews, mini-reviews, letters to the editor, and case reports relevant to the various fields of Pharmacology, Pharmaceutical Medicine (Pharmacy Practice; Hospital, Community and Clinical-Pharmacy), Pharmaceutics/Industrial Pharmacy, Pharmaceutical Technology, Nanotechnology, Biopharmaceutics, Pharmacokinetics, Pharmaceutical Chemistry/Medicinal Chemistry/Bulk Drugs, Pharmaceutical Analysis/Quality Assurance, Pharmacognosy & Phytochemistry/Natural Products, Regulatory Affairs & Pharmaceutical Marketing, Biotechnology, Toxicology, Microbiology, Biochemistry and Integrative Medicines etc.

Int J Adv Pharm Med Bioallied Sci utilizes a comprehensive systematic peer-review and editing process to assess manuscripts for scientific accuracy, innovation, and significance. Int J Adv Pharm Med Bioallied Sci commits to maintaining the reputation and integrity while using novel formats and expertise for new features and faster delivery and access. Following submission to the Editorial Board, articles are peer-reviewed and if accepted, are published in the next issue, resulting in immediate international exposure.

WHY PUBLISH IN INT J ADV PHARM MED BIOALLIED SCI (IJAPMBS)?

• Editorial board ensures a timely peer-review.
• Full-text articles published as open access (OA).
• Publishes in vivo and in-vitro findings in clinical and preclinical studies.
• Manuscripts will be freely available online.
• Multiple accesses of PDFs of published articles will be free of cost.
• Fast-track publication.
• A speedy decision on the submission.